Two weeks ago, Curevac filed a lawsuit in the German Regional Court in Düsseldorf against BioNTech over patent infringement alleging that BioNTech’s Covid-19 vaccine infringed its patents related to mRNA technology. In their press release, Curevac declared that no legal action which impedes the production, sale, or distribution of the vaccine will be taken. Instead, they seek only damages and royalties to be awarded based on past and future sales.
...
↧